AZD7687 Multiple Ascending Dose Study

NCT01119352 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

45

Enrollment

INDUSTRY

Sponsor class

Conditions

Overweight
Obese

Interventions

DRUG: AZD7687
DRUG: Placebo

Sponsor

AstraZeneca